Ideaya Biosciences Stock In The News

IDYA Stock  USD 37.58  0.75  1.96%   
Our overall analysis of Ideaya Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Ideaya Biosciences. The specific impact of Ideaya Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ideaya Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ideaya Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ideaya Biosciences Backtesting and Ideaya Biosciences Hype Analysis.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.

Ideaya Biosciences Today Top News and Investor Outlook

Yahoo News
IDEAYA Announces Results for Darovaserti...
https://finance.yahoo.com/news/ideaya-announces-results-darovasertib-phase-100000682.html
 Neutral
Yahoo News
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/ideaya-biosciences-announces-inducement-grants-100000484.html
 Bullish
Yahoo News
IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events
https://finance.yahoo.com/news/ideaya-biosciences-participate-upcoming-june-100000668.html
 Neutral
Yahoo News
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
https://finance.yahoo.com/news/ideaya-biosciences-appoints-daniel-simon-100000181.html
 Bullish
Yahoo News
/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
https://finance.yahoo.com/news/ideaya-biosciences-announces-abstract-summary-210500842.html
 Neutral
Yahoo News
IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)
https://finance.yahoo.com/news/ideaya-biosciences-first-quarter-2024-114140205.html
 Neutral
Yahoo News
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
https://finance.yahoo.com/news/ideaya-biosciences-inc-reports-first-100000644.html
 Neutral
sbwire news
IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
https://investorplace.com/earning-results/2024/05/idya-stock-earnings-ideaya-biosciences-for-q1-of-2024/
 Neutral
Yahoo News
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/ideaya-biosciences-announces-inducement-grants-100000248.html
 Bullish
Yahoo News
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
https://finance.yahoo.com/news/ideaya-biosciences-announces-asco-2024-140500390.html
 Neutral

Ideaya Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ideaya and other traded companies coverage with news coverage. We help investors stay connected with Ideaya headlines for the 12th of June 2024 to make an informed investment decision based on correlating the impacts of news items on Ideaya Stock performance. Please note that trading solely based on the Ideaya Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ideaya Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ideaya Biosciences investors visualize upcoming and past events in order to time the market based on Ideaya Biosciences noise-free hype analysis.
Ideaya Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ideaya earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ideaya Biosciences that are available to investors today. That information is available publicly through Ideaya media outlets and privately through word of mouth or via Ideaya internal channels. However, regardless of the origin, that massive amount of Ideaya data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ideaya Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ideaya Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ideaya Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ideaya Biosciences alpha.

Ideaya Largest EPS Surprises

Earnings surprises can significantly impact Ideaya Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-02-20
2023-12-31-0.47-0.52-0.0510 
2022-05-10
2022-03-31-0.41-0.360.0512 
2023-08-10
2023-06-30-0.56-0.50.0610 
2023-05-09
2023-03-31-0.55-0.490.0610 
2023-03-07
2022-12-31-0.56-0.50.0610 
2021-03-23
2020-12-31-0.3-0.180.1240 
View All Earnings Estimates

Ideaya Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ideaya Biosciences Stock. The global stock market is bearish. About 70% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
11th of June 2024
IDEAYA Biosciences, Inc. Stake Reduced by Avidity Partners Management LP - MarketBeat
at news.google.com 
Google News at Macroaxis
4th of June 2024
Campbell CO Investment Adviser LLC Increases Stock Holdings in IDEAYA Biosciences, Inc. - ...
at news.google.com 
Investing News at Macroaxis
31st of May 2024
Ideaya Biosciences CSO sells over 1m in company stock
at investing.com 
Yahoo News
29th of May 2024
Disposition of 851 shares by Michael White of Ideaya Biosciences at 36.7763 subject to Rul...
at finance.yahoo.com 
Google News at Macroaxis
20th of May 2024
First Week of January 2025 Options Trading For IDEAYA Biosciences - Nasdaq
at news.google.com 
Macroaxis News
15th of May 2024
Disposition of 83856 shares by Yujiro Hata of Ideaya Biosciences at 4.31 subject to Rule 1...
at MacroaxisInsider 
Yahoo News
7th of May 2024
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Busines...
at finance.yahoo.com 
Google News at Macroaxis
12th of April 2024
How To Trade - Stock Traders Daily
at news.google.com 

Ideaya Biosciences Investors Sentiment

The influence of Ideaya Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ideaya. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ideaya Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ideaya Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ideaya Biosciences' short interest history, or implied volatility extrapolated from Ideaya Biosciences options trading.

Additional Information and Resources on Investing in Ideaya Stock

When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:
Check out Ideaya Biosciences Backtesting and Ideaya Biosciences Hype Analysis.
For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.00)
Revenue Per Share
0.241
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.15)
Return On Equity
(0.20)
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.